Clomid (clomiphene citrate) is classified as a Prescription Only Medicine (POM) in the United Kingdom. It is not available for general sale or GSL supply without a prescription. Any purchase or order of Clomid in the UK should be based on a valid prescription issued by a qualified healthcare professional. However, many online pharmacies offer generic Clomid for sale without requiring a traditional paper prescription through remote consultation services. These services can provide access to affordable, cheaper and generic clomiphene citrate, subject to an approved online health assessment.
While some websites advertise generic Clomid without prescription, patients should ensure they use reputable online pharmacies that follow UK regulatory standards, carry out proper checks and supply genuine, high-quality medicine. Ordering Clomid online can be cheaper than purchasing branded products in a clinic or hospital pharmacy, but safety and authenticity must not be compromised for price.
In the UK, medications are classified into three main categories: Prescription Only Medicines (POM), Pharmacy medicines (P) and General Sales List medicines (GSL). A POM cannot be purchased or supplied without a valid prescription from a doctor, dentist or approved prescriber. Clomid falls under the POM category, so it must be prescribed for indications such as infertility, ovulation induction or certain endocrine disorders.
Pharmacy medicines (P) can be sold under the supervision of a pharmacist without a prescription, while GSL medicines can be sold in general retail outlets with minimal restrictions. The POM classification ensures a higher level of clinical oversight, specialist advice and monitoring, which is particularly important for medicines like clomiphene citrate that affect hormonal balance and fertility.
Clomiphene citrate is an oral fertility drug used to stimulate ovulation in women who have difficulty conceiving due to ovulatory dysfunction. It is commonly prescribed under the brand name Clomid, but generic versions contain the same active ingredient and have equivalent clinical effects when approved by UK regulators.
Clomiphene works by blocking estrogen receptors in the hypothalamus, which leads to increased release of gonadotropin-releasing hormone (GnRH). This in turn stimulates the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH), promoting maturation of ovarian follicles and triggering ovulation.
The active pharmaceutical ingredient is clomiphene citrate. Inactive ingredients vary between branded and generic Clomid products and may include lactose, microcrystalline cellulose, magnesium stearate and other excipients that affect tablet stability, appearance and gastrointestinal tolerability.
Generic Clomid offers the same clomiphene citrate dosage as branded products at a lower cost. Regulatory authorities require generics to demonstrate bioequivalence to the reference product, ensuring comparable safety, efficacy and quality.
Clomid is administered orally, which offers convenience and avoids the need for injections. Other fertility treatments like gonadotropins often require injectable administration, higher monitoring and increased cost.
Typical regimens involve a five-day course taken early in the menstrual cycle, but this can vary by patient response, ovarian function and clinician guidance. Treatment cycles are limited due to diminishing returns and potential risks.
Clomid modulates the feedback loop between the hypothalamus, pituitary gland and ovaries. By blocking estrogen receptors centrally, it simulates a low-estrogen environment, prompting the release of FSH and LH to support follicular growth and ovulation.
The rise in FSH stimulates the development of one or more dominant ovarian follicles. Ultrasound monitoring may be used to track follicle size and number, enabling dose adjustments to minimise multiple pregnancy risk.
Once a dominant follicle reaches the desired size, an LH surge – or a human chorionic gonadotropin (hCG) injection – may be used to trigger ovulation. Clomid itself can sometimes induce spontaneous ovulation without hCG.
Clomid is typically taken on cycle days 3–7 or 5–9. Ovulation generally occurs 5–10 days after the final dose, but individual responses vary. Patients track basal body temperature, ovulation predictor kits or ultrasound to confirm ovulation.
Effective ovulation induction increases the chance of conception but does not guarantee pregnancy. Fertility depends on multiple factors including sperm quality, tubal patency and uterine health. Clomid is part of a broader fertility management plan.
The price of clomiphene citrate varies by pack size, brand or generic status, retailer and any additional consultation fees for online ordering. Prices online can be significantly cheaper than private clinic rates. Always compare quotes and consider total order cost including shipping.
When you purchase clomiphene citrate from a UK-registered online pharmacy, you may complete a secure health questionnaire that is reviewed by a pharmacist or prescribing clinician. Once approved, the order can be dispatched to your home at a competitive price.
| Example | Strength | Formulation | Price (GBP) | Status | Note |
|---|---|---|---|---|---|
| Generic Clomid A | 50 mg | Film-coated tablet | £15.99 per 5-pack | Prescription Only | Order online with remote consultation |
| Branded Clomid | 50 mg | Tablet | £39.99 per 5-pack | Prescription Only | Ask Ivybridge Pharmacy for current price |
Clomiphene citrate is commonly supplied as 50 mg film-coated tablets. Some formulations offer 25 mg tablets to allow more precise dose adjustment by splitting tablets under clinical guidance.
Typical pack sizes include five, ten or twenty tablets. The pack size influences total cost and may form part of regulatory supply conditions such as maximum cycle duration or prescription validity.
While the packaging of generic products differs from the branded Clomid presentation, the same active ingredient dosage and quality standards apply. Always check the product leaflet for exact excipients and legal classification.
Under supervision, clinicians may recommend starting with a lower dose or incremental dose increases in subsequent cycles. Splitting 50 mg tablets can help tailor therapy for individual responses.
| Feature | Why it matters |
| Active ingredient | Clomiphene citrate determines ovulation induction effect |
| Strength | Dosage per tablet must match clinical protocol |
| Formulation | Gastrointestinal tolerability and absorption |
| Pack size | Reflected in total cycle availability and cost |
| Legal category | Requires prescription and professional oversight |
Clomid is indicated for the treatment of anovulatory infertility in women desiring pregnancy. It is especially useful in polycystic ovary syndrome (PCOS) where ovulation does not occur regularly.
Clinicians may prescribe Clomid off-label for unexplained infertility or mild endometriosis. Some specialist centres also use clomiphene citrate in low-dose protocols for poor ovarian responders in assisted reproduction.
In some cases, clomiphene is prescribed off-label for men with secondary hypogonadism to increase endogenous testosterone production. This use remains less common and requires endocrinology oversight.
Clinical evaluation often includes ultrasound monitoring of follicle development, serum estradiol levels and mid-luteal progesterone measurements to confirm ovulation and luteal function.
If more than two dominant follicles develop or estradiol levels exceed safe thresholds, treatment may be paused or canceled to reduce the risk of ovarian hyperstimulation and multiple pregnancy.
Due to its hormonal effects, potential side effects and need for monitoring, clomiphene citrate is classified as Prescription Only Medicine in the UK. It cannot be sold or supplied without a doctor’s prescription or an approved remote prescribing pathway.
Some UK-registered online pharmacies operate a remote clinical service where patients complete an online consultation reviewed by a prescriber. Once approved, a legally valid prescription is issued electronically, enabling purchase without a paper prescription.
The Medicines and Healthcare products Regulatory Agency (MHRA) oversees classification, licensing and safety monitoring of Clomid. Generic producers must hold a Marketing Authorisation demonstrating product quality and bioequivalence.
Buying Clomid from overseas suppliers without MHRA approval risks receiving substandard or counterfeit products. UK-registered pharmacies ensure compliance with regulatory standards and safe supply.
An aromatase inhibitor used off-label for ovulation induction, particularly in women with PCOS; often comparable or superior to clomiphene in some studies.
Injectable follicle-stimulating hormone preparations can induce ovulation in patients who do not respond to oral treatments, but require intensive monitoring and higher cost.
Protocols combining low-dose gonadotropins with clomiphene or letrozole may optimise follicular response in difficult cases while minimising multiple pregnancy risk.
Weight management, smoking cessation and stress reduction can improve ovulatory function and fertility outcomes when used alongside medical therapy.
Letrozole may produce a more favourable endometrial environment and lower multiple pregnancy rate in PCOS patients, but clomiphene remains widely used due to long-term data and clinician experience.
Gonadotrophins provide direct FSH stimulation and can achieve ovulation when Clomid fails, but carry a higher risk of ovarian hyperstimulation syndrome and multiple gestation.
| Feature | Clomiphene citrate | Letrozole | Gonadotrophins |
| Administration | Oral tablet | Oral tablet | Injectable |
| Mechanism | Estrogen receptor modulator | Aromatase inhibitor | Exogenous FSH |
| Monitoring | Moderate | Minimal | Intensive |
| Cost | Low | Low | High |
Choice depends on patient characteristics, underlying diagnosis, previous response, cost considerations and monitoring capacity. Generic Clomid is often the first-line due to affordability and convenience.
Clomid is commonly taken once daily for five days, starting on cycle day 3, 5 or as directed by the prescribing clinician. Tablets should be taken at the same time each day to maintain consistent blood levels.
Baseline ultrasound and hormonal profiling may guide initial dosing. Subsequent monitoring during the cycle can include mid-cycle ultrasound, estradiol assays and LH surge kits to confirm follicle growth and ovulation.
Maintaining a healthy body mass index can enhance treatment response. Weight loss in overweight women with PCOS can restore spontaneous ovulation and improve Clomid efficacy.
Moderate exercise is encouraged; excessive strenuous activity might disrupt menstrual cycles. Stress management techniques such as mindfulness or yoga can support overall fertility health.
Intercourse or insemination is typically recommended around the predicted ovulation window, 5–10 days after completion of Clomid, to maximise the chance of conception.
Hot flushes, mood swings, nausea, breast discomfort and headaches can occur. These effects are usually mild and self-limiting, resolving shortly after the end of the dosing cycle.
| Area | Examples described in product information |
| Vasomotor | Hot flushes, sweating |
| Central nervous | Headache, dizziness |
| GI | Nausea, abdominal discomfort |
| Visual | Blurred vision or spots (rare) |
| Psychological | Mood changes, irritability |
| Reproductive | Ovarian enlargement, multiple pregnancy risk |
Clomid carries a lower OHSS risk compared to gonadotrophins, but patients should report pelvic pain, rapid weight gain or bloating immediately for assessment and management.
Use of Clomid increases the chance of twins. Higher-order pregnancies are rare but possible, particularly with higher doses or in combination protocols.
Visual symptoms are uncommon but require immediate cessation of Clomid if experienced. These typically resolve after stopping the medication.
Clomid is generally restricted to six treatment cycles due to diminishing efficacy and cumulative risk. Clinicians may reassess after three cycles to determine next steps.
Repeated cycles can yield cumulative pregnancy rates, but after six failed cycles, alternative strategies such as gonadotrophins, intrauterine insemination or IVF may be explored.
No significant effects on nutrient absorption are documented with short-term Clomid use, but balanced nutrition supports ovarian response and overall health.
Long-term estrogen receptor modulation could theoretically affect bone density, but typical Clomid regimens are unlikely to have clinically meaningful impact.
Infertility treatment can be emotionally challenging. Counselling, support groups and open communication with healthcare providers are important components of care.
Clomid has few known drug interactions, but concurrent use of estrogen-containing medications or hormone therapies can alter its effectiveness. Always inform the prescriber of all medicines being taken.
Visual disturbances are a contraindication to further Clomid courses. A comprehensive eye examination may be advised for persistent symptoms.
Clomid should not be used once pregnancy is confirmed. Breastfeeding women should avoid Clomid unless the benefits outweigh potential risks and breastfeeding can be monitored.
Severe hypersensitivity is rare but may present with rash, itching or facial swelling. Seek immediate medical attention if such reactions occur.
Pelvic pain, severe bloating, vision changes or mood disorders require prompt evaluation rather than continued self-treatment.
A generic product contains the same active ingredient, dosage and therapeutic effect as the branded reference product. It must meet UK regulatory standards for quality, safety and bioequivalence.
Various manufacturers may produce generic Clomid tablets with different inactive ingredients, pack sizes and patient leaflets. Always read the leaflet that comes with your specific product.
Regulatory requirements ensure each authorised product’s leaflet includes the approved indication, dosage instructions, contraindications, side effects and monitoring guidelines specific to that formulation.
Trustworthy sources include the MHRA website, electronic Medicines Compendium (eMC) and qualified healthcare professionals. Do not rely on unverified overseas sites for clinical data.
No. This page provides general guidance only. For personalised advice, contact Ivybridge Pharmacy at 7 Erme Court, Ivybridge, Devon PL21 0SZ or call +44 1752 892245 to speak with our pharmacy team.